4D Molecular Therapeutics Inc (FDMT)

EBITDA Margin

-199.94%

TTM · Period ending:

FDMT logo

FDMT EBITDA Margin

Latest reported-199.94%
FDMT EBITDA Margin (-183.87% → -199.94%)
High-resolution chart · PNG

FDMT ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

4D Molecular Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-155.4812%
-416,656.7568%
-458.8525%
-3,311.4094%
-378.6285%
-405.6788%
-638.7489%
-68.6624%
-183.8687%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.